创伤大量输血患者血小板与红细胞输注比例与死亡率:系统评价与荟萃分析
该系统评价与荟萃分析检索4个数据库至2021年1月21日,共纳入59篇文章,其中12篇进入荟萃分析,比较创伤大量输血患者不同血小板/红细胞(PLT/RBC)比例对死亡率的影响。结果显示,高PLT/RBC比较低比例组在1–6小时、24小时及28–30天死亡率均显著降低。结论认为创伤大量输血的最佳PLT/RBC比例约为1:1。证据等级为治疗性Level III。
要点
- 创伤大量输血患者中,高PLT/RBC比较低比例组1–6小时死亡率显著降低。
- 高PLT/RBC比较低比例组24小时死亡率显著降低。
- 高PLT/RBC比较低比例组28–30天死亡率显著降低。
- 创伤大量输血的最佳PLT/RBC比例约为1:1。
- 该结论基于12项研究的荟萃分析,证据等级为治疗性Level III。
适用人群与场景
- 需要大量输血的创伤患者。
- 纳入比较不同PLT/RBC比例的研究;具体纳入/排除标准原文未提及。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型为系统评价与荟萃分析,检索4个数据库至2021年1月21日,共纳入59篇文章,其中12篇进入荟萃分析。
- 主要结局为1–6小时、24小时及28–30天死亡率;高PLT/RBC比较低PLT/RBC比例组上述死亡率均显著降低。
- 次要结局包括ICU住院时间、住院时间及总血液成分使用量;具体结果原文未提及。
- 结论认为创伤大量输血的最佳PLT/RBC比例约为1:1。
证据类型、等级与局限
- 证据类型为系统评价与荟萃分析,治疗性证据等级Level III。
- 局限:原文未提及具体局限;设计上为对观察性研究的荟萃分析,具体研究设计原文未提及。
对床旁实践的改变
- 对需要大量输血的创伤患者,可考虑采用较高的PLT/RBC比例(约1:1)以降低1–6小时、24小时及28–30天死亡率。
- 适用人群为需要大量输血的创伤患者;不适用人群及具体排除标准原文未提及。
- 常见陷阱:原文未提及。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Platelet transfusion during major hemorrhage is important and often embedded in massive transfusion protocols. However, the optimal ratio of platelets to erythrocytes (platelet-rich plasma [PLT]/red blood cell [RBC] ratio) remains unclear. We hypothesized that high PLT/RBC ratios, as compared with low PLT/RBC ratios, are associated with improved survival in patients requiring massive transfusion.
METHODS: Four databases (Pubmed, CINAHL, EMBASE, and Cochrane) were systematically screened for literatures published until January 21, 2021, to determine the effect of PLT/RBC ratio on the primary outcome measure mortality at 1 hour to 6 hours and 24 hours and at 28 days to 30 days. Studies comparing various PLT/RBC ratios were included in the meta-analysis. Secondary outcomes included intensive care unit length of stay and in-hospital length of stay and total blood component use. The study protocol was registered in PROSPERO under number CRD42020165648.
RESULTS: The search identified a total of 8903 records. After removing the duplicates and second screening of title, abstract, and full text, a total of 59 articles were included in the analysis. Of these articles, 12 were included in the meta-analysis. Mortality at 1 hour to 6 hours, 24 hours, and 28 days to 30 days was significantly lower for high PLT/RBC ratios as compared with low PLT/RBC ratios.
CONCLUSION: Higher PLT/RBC ratios are associated with significantly lower 1-hour to 6-hour, 24-hour, 28-day to 30-day mortalities as compared with lower PLT/RBC ratios. The optimal PLT/RBC ratio for massive transfusion in trauma patients is approximately 1:1.
LEVEL OF EVIDENCE: Systematic review and meta-analysis, therapeutic Level III.
参考来源
- Rijnhout TWH, Duijst J, Noorman F, et al. Platelet to erythrocyte transfusion ratio and mortality in massively transfused trauma patients. A systematic review and meta-analysis. J Trauma Acute Care Surg. 2021. PMID: 34225351. doi:10.1097/TA.0000000000003323
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。